Nanobodies to treat SARSCoV2 moving towards clinical trials
Prof Xavier Staelens, Group Leader at the VIB-UGent Center for Medical Biotechnology, VIB, Ghent, Belgium
Balance between COVID19 diseases and societal impact
Prof Lieven Annemans, Ghent University and Brussels University (VUB), Ghent, Belgium
Create your
podcast in
minutes
It is Free